nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefepime—Muscle mass—Prednisolone—ankylosing spondylitis	0.0611	0.0611	CcSEcCtD
Cefepime—Ca++ increased—Methylprednisolone—ankylosing spondylitis	0.0605	0.0605	CcSEcCtD
Cefepime—Muscle mass—Triamcinolone—ankylosing spondylitis	0.0562	0.0562	CcSEcCtD
Cefepime—Muscle mass—Methylprednisolone—ankylosing spondylitis	0.056	0.056	CcSEcCtD
Cefepime—Muscle mass—Betamethasone—ankylosing spondylitis	0.051	0.051	CcSEcCtD
Cefepime—Muscle mass—Dexamethasone—ankylosing spondylitis	0.051	0.051	CcSEcCtD
Cefepime—Potassium increased—Prednisone—ankylosing spondylitis	0.0444	0.0444	CcSEcCtD
Cefepime—Muscle mass—Prednisone—ankylosing spondylitis	0.0444	0.0444	CcSEcCtD
Cefepime—Septicemia—Methotrexate—ankylosing spondylitis	0.0221	0.0221	CcSEcCtD
Cefepime—Blood potassium increased—Prednisone—ankylosing spondylitis	0.0199	0.0199	CcSEcCtD
Cefepime—Neurotoxicity—Methotrexate—ankylosing spondylitis	0.0129	0.0129	CcSEcCtD
Cefepime—Hypercalcaemia—Methylprednisolone—ankylosing spondylitis	0.0109	0.0109	CcSEcCtD
Cefepime—Extravasation—Dexamethasone—ankylosing spondylitis	0.00791	0.00791	CcSEcCtD
Cefepime—Extravasation—Betamethasone—ankylosing spondylitis	0.00791	0.00791	CcSEcCtD
Cefepime—Encephalopathy—Methotrexate—ankylosing spondylitis	0.00782	0.00782	CcSEcCtD
Cefepime—Inflammation—Methylprednisolone—ankylosing spondylitis	0.00782	0.00782	CcSEcCtD
Cefepime—Liver disorder—Methotrexate—ankylosing spondylitis	0.00737	0.00737	CcSEcCtD
Cefepime—Candida infection—Triamcinolone—ankylosing spondylitis	0.00726	0.00726	CcSEcCtD
Cefepime—Stupor—Methotrexate—ankylosing spondylitis	0.00672	0.00672	CcSEcCtD
Cefepime—Blood alkaline phosphatase increased—Methylprednisolone—ankylosing spondylitis	0.00633	0.00633	CcSEcCtD
Cefepime—Extravasation—Methotrexate—ankylosing spondylitis	0.00575	0.00575	CcSEcCtD
Cefepime—Sepsis—Prednisone—ankylosing spondylitis	0.00521	0.00521	CcSEcCtD
Cefepime—Inflammation—Methotrexate—ankylosing spondylitis	0.00518	0.00518	CcSEcCtD
Cefepime—Vaginal inflammation—Methotrexate—ankylosing spondylitis	0.00502	0.00502	CcSEcCtD
Cefepime—Alanine aminotransferase increased—Methylprednisolone—ankylosing spondylitis	0.00486	0.00486	CcSEcCtD
Cefepime—Depressed level of consciousness—Methotrexate—ankylosing spondylitis	0.00485	0.00485	CcSEcCtD
Cefepime—Vaginal infection—Methotrexate—ankylosing spondylitis	0.00474	0.00474	CcSEcCtD
Cefepime—Aplastic anaemia—Methotrexate—ankylosing spondylitis	0.00471	0.00471	CcSEcCtD
Cefepime—Coma—Methotrexate—ankylosing spondylitis	0.00459	0.00459	CcSEcCtD
Cefepime—Bronchitis—Triamcinolone—ankylosing spondylitis	0.00459	0.00459	CcSEcCtD
Cefepime—Sepsis—Methotrexate—ankylosing spondylitis	0.00436	0.00436	CcSEcCtD
Cefepime—Haemoglobin—Prednisolone—ankylosing spondylitis	0.00417	0.00417	CcSEcCtD
Cefepime—Haemorrhage—Prednisolone—ankylosing spondylitis	0.00415	0.00415	CcSEcCtD
Cefepime—Hepatic failure—Methotrexate—ankylosing spondylitis	0.00406	0.00406	CcSEcCtD
Cefepime—Alanine aminotransferase increased—Prednisone—ankylosing spondylitis	0.00385	0.00385	CcSEcCtD
Cefepime—Haemoglobin—Triamcinolone—ankylosing spondylitis	0.00384	0.00384	CcSEcCtD
Cefepime—Haemoglobin—Methylprednisolone—ankylosing spondylitis	0.00383	0.00383	CcSEcCtD
Cefepime—Haemorrhage—Triamcinolone—ankylosing spondylitis	0.00382	0.00382	CcSEcCtD
Cefepime—Haemorrhage—Methylprednisolone—ankylosing spondylitis	0.00381	0.00381	CcSEcCtD
Cefepime—Hallucination—Methylprednisolone—ankylosing spondylitis	0.00379	0.00379	CcSEcCtD
Cefepime—Erythema—Prednisolone—ankylosing spondylitis	0.00361	0.00361	CcSEcCtD
Cefepime—Neutropenia—Prednisone—ankylosing spondylitis	0.00352	0.00352	CcSEcCtD
Cefepime—Haemoglobin—Dexamethasone—ankylosing spondylitis	0.00348	0.00348	CcSEcCtD
Cefepime—Haemoglobin—Betamethasone—ankylosing spondylitis	0.00348	0.00348	CcSEcCtD
Cefepime—Haemorrhage—Dexamethasone—ankylosing spondylitis	0.00346	0.00346	CcSEcCtD
Cefepime—Haemorrhage—Betamethasone—ankylosing spondylitis	0.00346	0.00346	CcSEcCtD
Cefepime—Hallucination—Dexamethasone—ankylosing spondylitis	0.00345	0.00345	CcSEcCtD
Cefepime—Hallucination—Betamethasone—ankylosing spondylitis	0.00345	0.00345	CcSEcCtD
Cefepime—Erythema—Triamcinolone—ankylosing spondylitis	0.00332	0.00332	CcSEcCtD
Cefepime—Erythema—Methylprednisolone—ankylosing spondylitis	0.00332	0.00332	CcSEcCtD
Cefepime—Toxic epidermal necrolysis—Methotrexate—ankylosing spondylitis	0.00328	0.00328	CcSEcCtD
Cefepime—Dysgeusia—Triamcinolone—ankylosing spondylitis	0.00325	0.00325	CcSEcCtD
Cefepime—Convulsion—Prednisolone—ankylosing spondylitis	0.00313	0.00313	CcSEcCtD
Cefepime—Eosinophilia—Methotrexate—ankylosing spondylitis	0.00312	0.00312	CcSEcCtD
Cefepime—Haemoglobin—Prednisone—ankylosing spondylitis	0.00303	0.00303	CcSEcCtD
Cefepime—Haemorrhage—Prednisone—ankylosing spondylitis	0.00302	0.00302	CcSEcCtD
Cefepime—Erythema—Dexamethasone—ankylosing spondylitis	0.00302	0.00302	CcSEcCtD
Cefepime—Erythema—Betamethasone—ankylosing spondylitis	0.00302	0.00302	CcSEcCtD
Cefepime—Hallucination—Prednisone—ankylosing spondylitis	0.003	0.003	CcSEcCtD
Cefepime—Pancytopenia—Methotrexate—ankylosing spondylitis	0.00299	0.00299	CcSEcCtD
Cefepime—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.00295	0.00295	CcSEcCtD
Cefepime—Neutropenia—Methotrexate—ankylosing spondylitis	0.00295	0.00295	CcSEcCtD
Cefepime—Shock—Prednisolone—ankylosing spondylitis	0.0029	0.0029	CcSEcCtD
Cefepime—Convulsion—Triamcinolone—ankylosing spondylitis	0.00288	0.00288	CcSEcCtD
Cefepime—Convulsion—Methylprednisolone—ankylosing spondylitis	0.00287	0.00287	CcSEcCtD
Cefepime—Pneumonia—Methotrexate—ankylosing spondylitis	0.00282	0.00282	CcSEcCtD
Cefepime—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.00278	0.00278	CcSEcCtD
Cefepime—Renal failure—Methotrexate—ankylosing spondylitis	0.00276	0.00276	CcSEcCtD
Cefepime—Confusional state—Methylprednisolone—ankylosing spondylitis	0.00273	0.00273	CcSEcCtD
Cefepime—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.00271	0.00271	CcSEcCtD
Cefepime—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.00271	0.00271	CcSEcCtD
Cefepime—Infection—Triamcinolone—ankylosing spondylitis	0.00269	0.00269	CcSEcCtD
Cefepime—Infection—Methylprednisolone—ankylosing spondylitis	0.00269	0.00269	CcSEcCtD
Cefepime—Shock—Triamcinolone—ankylosing spondylitis	0.00267	0.00267	CcSEcCtD
Cefepime—Shock—Methylprednisolone—ankylosing spondylitis	0.00266	0.00266	CcSEcCtD
Cefepime—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00265	0.00265	CcSEcCtD
Cefepime—Erythema—Prednisone—ankylosing spondylitis	0.00263	0.00263	CcSEcCtD
Cefepime—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.00262	0.00262	CcSEcCtD
Cefepime—Convulsion—Dexamethasone—ankylosing spondylitis	0.00261	0.00261	CcSEcCtD
Cefepime—Convulsion—Betamethasone—ankylosing spondylitis	0.00261	0.00261	CcSEcCtD
Cefepime—Haemoglobin—Methotrexate—ankylosing spondylitis	0.00253	0.00253	CcSEcCtD
Cefepime—Pain—Prednisolone—ankylosing spondylitis	0.00252	0.00252	CcSEcCtD
Cefepime—Haemorrhage—Methotrexate—ankylosing spondylitis	0.00252	0.00252	CcSEcCtD
Cefepime—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.00246	0.00246	CcSEcCtD
Cefepime—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.00246	0.00246	CcSEcCtD
Cefepime—Infection—Betamethasone—ankylosing spondylitis	0.00244	0.00244	CcSEcCtD
Cefepime—Infection—Dexamethasone—ankylosing spondylitis	0.00244	0.00244	CcSEcCtD
Cefepime—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.00244	0.00244	CcSEcCtD
Cefepime—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00243	0.00243	CcSEcCtD
Cefepime—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00243	0.00243	CcSEcCtD
Cefepime—Anaemia—Prednisone—ankylosing spondylitis	0.00243	0.00243	CcSEcCtD
Cefepime—Shock—Dexamethasone—ankylosing spondylitis	0.00242	0.00242	CcSEcCtD
Cefepime—Shock—Betamethasone—ankylosing spondylitis	0.00242	0.00242	CcSEcCtD
Cefepime—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00242	0.00242	CcSEcCtD
Cefepime—Agitation—Prednisone—ankylosing spondylitis	0.00241	0.00241	CcSEcCtD
Cefepime—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.00241	0.00241	CcSEcCtD
Cefepime—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.00241	0.00241	CcSEcCtD
Cefepime—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.00238	0.00238	CcSEcCtD
Cefepime—Urticaria—Prednisolone—ankylosing spondylitis	0.00234	0.00234	CcSEcCtD
Cefepime—Pain—Triamcinolone—ankylosing spondylitis	0.00232	0.00232	CcSEcCtD
Cefepime—Convulsion—Prednisone—ankylosing spondylitis	0.00228	0.00228	CcSEcCtD
Cefepime—Chills—Methotrexate—ankylosing spondylitis	0.00226	0.00226	CcSEcCtD
Cefepime—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.00224	0.00224	CcSEcCtD
Cefepime—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.00223	0.00223	CcSEcCtD
Cefepime—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00221	0.00221	CcSEcCtD
Cefepime—Paraesthesia—Betamethasone—ankylosing spondylitis	0.00221	0.00221	CcSEcCtD
Cefepime—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.00221	0.00221	CcSEcCtD
Cefepime—Erythema—Methotrexate—ankylosing spondylitis	0.00219	0.00219	CcSEcCtD
Cefepime—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00217	0.00217	CcSEcCtD
Cefepime—Urticaria—Triamcinolone—ankylosing spondylitis	0.00215	0.00215	CcSEcCtD
Cefepime—Urticaria—Methylprednisolone—ankylosing spondylitis	0.00215	0.00215	CcSEcCtD
Cefepime—Dysgeusia—Methotrexate—ankylosing spondylitis	0.00215	0.00215	CcSEcCtD
Cefepime—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.00214	0.00214	CcSEcCtD
Cefepime—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.00214	0.00214	CcSEcCtD
Cefepime—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00214	0.00214	CcSEcCtD
Cefepime—Infection—Prednisone—ankylosing spondylitis	0.00213	0.00213	CcSEcCtD
Cefepime—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00212	0.00212	CcSEcCtD
Cefepime—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00212	0.00212	CcSEcCtD
Cefepime—Shock—Prednisone—ankylosing spondylitis	0.00211	0.00211	CcSEcCtD
Cefepime—Pain—Dexamethasone—ankylosing spondylitis	0.0021	0.0021	CcSEcCtD
Cefepime—Pain—Betamethasone—ankylosing spondylitis	0.0021	0.0021	CcSEcCtD
Cefepime—Anaemia—Methotrexate—ankylosing spondylitis	0.00203	0.00203	CcSEcCtD
Cefepime—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.00203	0.00203	CcSEcCtD
Cefepime—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.00203	0.00203	CcSEcCtD
Cefepime—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00201	0.00201	CcSEcCtD
Cefepime—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00201	0.00201	CcSEcCtD
Cefepime—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.002	0.002	CcSEcCtD
Cefepime—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00199	0.00199	CcSEcCtD
Cefepime—Leukopenia—Methotrexate—ankylosing spondylitis	0.00196	0.00196	CcSEcCtD
Cefepime—Urticaria—Dexamethasone—ankylosing spondylitis	0.00196	0.00196	CcSEcCtD
Cefepime—Urticaria—Betamethasone—ankylosing spondylitis	0.00196	0.00196	CcSEcCtD
Cefepime—Dizziness—Prednisolone—ankylosing spondylitis	0.00195	0.00195	CcSEcCtD
Cefepime—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00195	0.00195	CcSEcCtD
Cefepime—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00195	0.00195	CcSEcCtD
Cefepime—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.00195	0.00195	CcSEcCtD
Cefepime—Body temperature increased—Betamethasone—ankylosing spondylitis	0.00195	0.00195	CcSEcCtD
Cefepime—Paraesthesia—Prednisone—ankylosing spondylitis	0.00192	0.00192	CcSEcCtD
Cefepime—Pruritus—Triamcinolone—ankylosing spondylitis	0.00192	0.00192	CcSEcCtD
Cefepime—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00191	0.00191	CcSEcCtD
Cefepime—Convulsion—Methotrexate—ankylosing spondylitis	0.0019	0.0019	CcSEcCtD
Cefepime—Rash—Prednisolone—ankylosing spondylitis	0.00186	0.00186	CcSEcCtD
Cefepime—Dermatitis—Prednisolone—ankylosing spondylitis	0.00186	0.00186	CcSEcCtD
Cefepime—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00185	0.00185	CcSEcCtD
Cefepime—Headache—Prednisolone—ankylosing spondylitis	0.00185	0.00185	CcSEcCtD
Cefepime—Constipation—Prednisone—ankylosing spondylitis	0.00183	0.00183	CcSEcCtD
Cefepime—Confusional state—Methotrexate—ankylosing spondylitis	0.00181	0.00181	CcSEcCtD
Cefepime—Dizziness—Triamcinolone—ankylosing spondylitis	0.00179	0.00179	CcSEcCtD
Cefepime—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.00179	0.00179	CcSEcCtD
Cefepime—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00179	0.00179	CcSEcCtD
Cefepime—Infection—Methotrexate—ankylosing spondylitis	0.00178	0.00178	CcSEcCtD
Cefepime—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00177	0.00177	CcSEcCtD
Cefepime—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.00175	0.00175	CcSEcCtD
Cefepime—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00175	0.00175	CcSEcCtD
Cefepime—Nausea—Prednisolone—ankylosing spondylitis	0.00175	0.00175	CcSEcCtD
Cefepime—Pruritus—Dexamethasone—ankylosing spondylitis	0.00174	0.00174	CcSEcCtD
Cefepime—Pruritus—Betamethasone—ankylosing spondylitis	0.00174	0.00174	CcSEcCtD
Cefepime—Vomiting—Triamcinolone—ankylosing spondylitis	0.00172	0.00172	CcSEcCtD
Cefepime—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00172	0.00172	CcSEcCtD
Cefepime—Rash—Triamcinolone—ankylosing spondylitis	0.00171	0.00171	CcSEcCtD
Cefepime—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00171	0.00171	CcSEcCtD
Cefepime—Rash—Methylprednisolone—ankylosing spondylitis	0.00171	0.00171	CcSEcCtD
Cefepime—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.0017	0.0017	CcSEcCtD
Cefepime—Urticaria—Prednisone—ankylosing spondylitis	0.0017	0.0017	CcSEcCtD
Cefepime—Headache—Triamcinolone—ankylosing spondylitis	0.0017	0.0017	CcSEcCtD
Cefepime—Headache—Methylprednisolone—ankylosing spondylitis	0.0017	0.0017	CcSEcCtD
Cefepime—Abdominal pain—Prednisone—ankylosing spondylitis	0.00169	0.00169	CcSEcCtD
Cefepime—Body temperature increased—Prednisone—ankylosing spondylitis	0.00169	0.00169	CcSEcCtD
Cefepime—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00168	0.00168	CcSEcCtD
Cefepime—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00168	0.00168	CcSEcCtD
Cefepime—Dizziness—Dexamethasone—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Cefepime—Dizziness—Betamethasone—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Cefepime—Nausea—Triamcinolone—ankylosing spondylitis	0.00161	0.00161	CcSEcCtD
Cefepime—Paraesthesia—Methotrexate—ankylosing spondylitis	0.00161	0.00161	CcSEcCtD
Cefepime—Nausea—Methylprednisolone—ankylosing spondylitis	0.00161	0.00161	CcSEcCtD
Cefepime—Dyspnoea—Methotrexate—ankylosing spondylitis	0.0016	0.0016	CcSEcCtD
Cefepime—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00158	0.00158	CcSEcCtD
Cefepime—Vomiting—Dexamethasone—ankylosing spondylitis	0.00156	0.00156	CcSEcCtD
Cefepime—Vomiting—Betamethasone—ankylosing spondylitis	0.00156	0.00156	CcSEcCtD
Cefepime—Rash—Betamethasone—ankylosing spondylitis	0.00155	0.00155	CcSEcCtD
Cefepime—Rash—Dexamethasone—ankylosing spondylitis	0.00155	0.00155	CcSEcCtD
Cefepime—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00155	0.00155	CcSEcCtD
Cefepime—Dermatitis—Betamethasone—ankylosing spondylitis	0.00155	0.00155	CcSEcCtD
Cefepime—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.00155	0.00155	CcSEcCtD
Cefepime—Headache—Betamethasone—ankylosing spondylitis	0.00154	0.00154	CcSEcCtD
Cefepime—Headache—Dexamethasone—ankylosing spondylitis	0.00154	0.00154	CcSEcCtD
Cefepime—Pain—Methotrexate—ankylosing spondylitis	0.00153	0.00153	CcSEcCtD
Cefepime—Pruritus—Prednisone—ankylosing spondylitis	0.00152	0.00152	CcSEcCtD
Cefepime—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.00148	0.00148	CcSEcCtD
Cefepime—Diarrhoea—Prednisone—ankylosing spondylitis	0.00147	0.00147	CcSEcCtD
Cefepime—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.00146	0.00146	CcSEcCtD
Cefepime—Nausea—Dexamethasone—ankylosing spondylitis	0.00146	0.00146	CcSEcCtD
Cefepime—Nausea—Betamethasone—ankylosing spondylitis	0.00146	0.00146	CcSEcCtD
Cefepime—Urticaria—Methotrexate—ankylosing spondylitis	0.00142	0.00142	CcSEcCtD
Cefepime—Dizziness—Prednisone—ankylosing spondylitis	0.00142	0.00142	CcSEcCtD
Cefepime—Abdominal pain—Methotrexate—ankylosing spondylitis	0.00142	0.00142	CcSEcCtD
Cefepime—Body temperature increased—Methotrexate—ankylosing spondylitis	0.00142	0.00142	CcSEcCtD
Cefepime—Vomiting—Prednisone—ankylosing spondylitis	0.00136	0.00136	CcSEcCtD
Cefepime—Rash—Prednisone—ankylosing spondylitis	0.00135	0.00135	CcSEcCtD
Cefepime—Dermatitis—Prednisone—ankylosing spondylitis	0.00135	0.00135	CcSEcCtD
Cefepime—Headache—Prednisone—ankylosing spondylitis	0.00134	0.00134	CcSEcCtD
Cefepime—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.00132	0.00132	CcSEcCtD
Cefepime—Nausea—Prednisone—ankylosing spondylitis	0.00127	0.00127	CcSEcCtD
Cefepime—Pruritus—Methotrexate—ankylosing spondylitis	0.00127	0.00127	CcSEcCtD
Cefepime—Diarrhoea—Methotrexate—ankylosing spondylitis	0.00123	0.00123	CcSEcCtD
Cefepime—Dizziness—Methotrexate—ankylosing spondylitis	0.00118	0.00118	CcSEcCtD
Cefepime—Vomiting—Methotrexate—ankylosing spondylitis	0.00114	0.00114	CcSEcCtD
Cefepime—Rash—Methotrexate—ankylosing spondylitis	0.00113	0.00113	CcSEcCtD
Cefepime—Dermatitis—Methotrexate—ankylosing spondylitis	0.00113	0.00113	CcSEcCtD
Cefepime—Headache—Methotrexate—ankylosing spondylitis	0.00112	0.00112	CcSEcCtD
Cefepime—Nausea—Methotrexate—ankylosing spondylitis	0.00106	0.00106	CcSEcCtD
